On this page
What each program costs in Florida
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of Florida employee health plan (Division of State Group Insurance) cover GLP-1s for weight loss?
Florida's state employee plan offers FDA-approved weight management medications only through its Weight Management Program, which is limited to 2,800 members who meet its eligibility criteria.
Florida Division of State Group Insurance
The 2026 benefits guide says the Weight Management Program pairs a wellness program with FDA-approved weight management medications.
“The Weight Management Program (WMP) provides access to a wellness program and FDA-approved weight management medications.”
https://www.mybenefits.myflorida.com/content/download/438643/file/2026%20Florida%20Benefit%20Guide.pdf · read Oct 29, 2026
Florida Division of State Group Insurance
The program is capped at 2,800 members.
“This program is available to 2,800 members who meet the eligibility criteria.”
https://www.mybenefits.myflorida.com/content/download/438643/file/2026%20Florida%20Benefit%20Guide.pdf · read Oct 29, 2026
What do Florida's big insurers publish on Wegovy and Zepbound?
Florida Blue
Florida Blue's January 2025 provider notice says medications used for weight loss or weight management are excluded from its health insurance plans, so authorization requests for Wegovy, Zepbound or Saxenda for weight loss are denied.
Florida Blue
Florida Blue's January 2025 notice on GLP-1 prior authorization for commercial plans states the weight-loss exclusion.
“Medications used for weight loss/management are excluded from coverage under Florida Blue’s health insurance plans.”
https://files.guidewell.com/m/7bf6733fcce9a9ab/original/providers-news-2025-pharmacy-glp-commercial-prior-auth-requirement-01-2025.pdf · read Oct 29, 2026
Florida Blue
The same notice says weight-loss requests for Wegovy, Zepbound or Saxenda are denied.
“Requesting an authorization for drugs like Wegovy, Zepbound, Saxenda, or other medications for weight loss/management will result in denial and patients will have to pay out of pocket.”
https://files.guidewell.com/m/7bf6733fcce9a9ab/original/providers-news-2025-pharmacy-glp-commercial-prior-auth-requirement-01-2025.pdf · read Oct 29, 2026
Does Florida Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Florida Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.
Weight loss
Not covered, January 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
1,166 prescriptions
Ozempic and Mounjaro, 2025
103,797 prescriptions
Neighbours covering weight loss
0 of 2
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. KFF counts coverage under fee-for-service; if your Florida Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
What may have changed since January
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Florida Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Florida Medicaid pay for?
133,402 GLP-1 prescriptions in 2025, 21st of the 50 states and DC, with $127.3 million reimbursed before rebates. Counting the share other payers covered, $128.0 million.
Prescriptions, 2025
133,402
21st of 51
Medicaid paid
$127.3M
21st of 51, before rebates
Per prescription
$954
$1,051 nationally
Weight-loss brands
0.9%
41st highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Florida is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.9% of Florida Medicaid's GLP-1 prescriptions in 2025 (1,166). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Ozempic was Florida Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Ozempic | 88,511 | 66% | $84.4 million | $953 |
| Trulicity | 26,544 | 20% | $24.7 million | $929 |
| Mounjaro | 15,286 | 11% | $15.5 million | $1,016 |
| Wegovyapproved for weight management | 975 | 0.7% | $1.2 million | $1,280 |
| Rybelsus | 923 | 0.7% | $877,306 | $950 |
| Liraglutide (generic) | 644 | 0.5% | $207,374 | $322 |
| Victoza | 242 | 0.2% | $135,460 | $560 |
| Zepboundapproved for weight management | 191 | 0.1% | $197,852 | $1,036 |
| Bydureon | 62 | 0.0% | $45,320 | $731 |
| Byetta | 24 | 0.0% | $19,517 | $813 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Florida?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 16 in Florida. The register does not say which, if any, supplies a program on this page.
- 503B Outsourcing Facility One, LLC, West Palm Beach. Registered since Feb 18, 2025; not yet inspected by FDA.
- Ajenat Pharmaceuticals, LLC, Largo. Registered since Mar 26, 2025; not yet inspected by FDA.
- Assure Infusions, Inc., Bartow. Registered since Nov 22, 2024; last FDA inspection Sep 17, 2026.
- Aveva Drug Delivery Systems, Inc, Tamarac. Registered since Nov 4, 2024; not yet inspected by FDA.
- BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy, Temple Terrace. Registered since Jun 4, 2019; last FDA inspection Mar 12, 2026.
- BPI Labs LLC, Largo. Registered since Mar 4, 2019; last FDA inspection Apr 17, 2026.
- Bravado Pharmaceuticals, LLC, Lutz. Registered since Feb 28, 2025; not yet inspected by FDA.
- GenoGenix LLC, Raton. Registered since Feb 4, 2025; last FDA inspection Jul 18, 2025.
- Leesar Inc., Fort Myers. Registered since Apr 30, 2014; last FDA inspection Sep 28, 2026.
- Navinta III Inc., Boca Raton. Registered since Feb 6, 2026; not yet inspected by FDA.
- Olympia Pharmaceuticals, Orlando. Registered since Mar 10, 2014; last FDA inspection Sep 3, 2026.
- PQ Pharmacy LLC, Brooksville. Registered since Oct 29, 2020; last FDA inspection Jun 1, 2026.
- Signature Rx, Delray Beach. Registered since Oct 13, 2023; not yet inspected by FDA.
- SKNV formerly registered as Sincerus Florida, LLC, Pompano Beach. Registered since Mar 10, 2016; last FDA inspection May 29, 2026.
- Strive Outsourcing LLC, Alachua. Registered since Oct 23, 2026; not yet inspected by FDA.
- Wesley Pharmaceuticals, Orlando. Registered since Jul 25, 2025; last FDA inspection Mar 16, 2026.
On Medicare in Florida?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Florida and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 2 states next to Florida covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Florida's $39.






















